3.8 Article

Triazine based chemical entities for anticancer activity

Journal

PHYSICAL SCIENCES REVIEWS
Volume -, Issue -, Pages -

Publisher

WALTER DE GRUYTER GMBH
DOI: 10.1515/psr-2022-0005

Keywords

anticancer activity; kinase inhibitors; several kinases; therapeutic value; triazine synthesis

Ask authors/readers for more resources

This chapter focuses on the synthesis, characterization, evaluation of anticancer properties, and the journey of triazine-based derivatives towards potential cancer medicine.
Triazine is a six-membered aromatic nitrogen heterocyclic moiety that was extensively investigated because of its biological properties and, in particular anticancer potentials. Kinases play a crucial role in cancer cell proliferation and metabolism. Triazine derivatives show anticancer activity by inhibiting the lipid kinases like phosphoinositide 3-kinases, mammalian target of rapamycin, receptor tyrosine kinases, like focal adhesion kinase, cyclin-dependent kinases, Rho-associated protein kinases, p21-activated kinases, carbonic anhydrases, enolase inhibitors, microtubules inhibitors, and histone deacetylases. The present chapter highlights the synthesis of triazine-based derivatives, their characterization, evaluation of anticancer properties, and their journey towards possible medicine for cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available